4.7 Article

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

Joan Carles Trullas et al.

Summary: This study aims to evaluate whether adding hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF). The study found that adding HCTZ to loop diuretic therapy can improve diuretic response in patients with AHF, but may also lead to renal function impairment.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

Jan Biegus et al.

Summary: This study evaluated the decongestion effects of empagliflozin in patients with acute heart failure (AHF) and found that compared to placebo, empagliflozin significantly reduced markers of decongestion at all time-points. Patients with greater weight loss within the first 15 days showed higher clinical benefit at Day 90.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Sodium and potassium changes during decongestion with acetazolamide - a pre-specified analysis from the ADVOR trial

Sebastiaan Dhont et al.

Summary: This study analyzed the effects of acetazolamide on serum sodium and potassium levels in patients with acute heart failure. The results showed that acetazolamide had a slight impact on blood potassium levels during treatment, but did not cause clinically significant hypokalemia or hyponatremia. Acetazolamide improved decongestion in patients with varying baseline serum sodium and potassium levels.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial

Pieter Martens et al.

Summary: Acetazolamide improved decongestion and diuretic response in patients with acute decompensated heart failure, regardless of their baseline left ventricular ejection fraction (LVEF).

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Worsening renal function in acute heart failure in the context of diuretic response

Johanna E. Emmens et al.

Summary: In two large cohorts of patients with acute heart failure (AHF), the occurrence of worsening renal function (WRF) in the first 4 days was not associated with worse outcomes when patients had a good diuretic response. The interaction between diuretic response and WRF should be considered in the management of AHF patients.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Medicine, General & Internal

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

Muthiah Vaduganathan et al.

Summary: This study conducted a meta-analysis of the therapeutic effects of SGLT2 inhibitors in heart failure patients, showing that these drugs can significantly reduce the risk of cardiovascular death and hospitalization for heart failure in heart failure patients, demonstrating their importance in foundational treatment.

LANCET (2022)

Article Medicine, General & Internal

Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

Wilfried Mullens et al.

Summary: The addition of acetazolamide to loop diuretic therapy in patients with acute decompensated heart failure results in a higher incidence of successful decongestion without increasing adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Loop diuretic resistance complicating acute heart failure

Zachary L. Cox et al.

HEART FAILURE REVIEWS (2020)

Article Cardiac & Cardiovascular Systems

Quantification of pleural effusions on thoracic ultrasound in acute heart failure

Moritz Lindner et al.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)

Review Peripheral Vascular Disease

Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors

Christopher S. Wilcox

HYPERTENSION (2020)

Article Cardiac & Cardiovascular Systems

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure

Zachary L. Cox et al.

JACC-HEART FAILURE (2020)

Review Cardiac & Cardiovascular Systems

Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review

G. Michael Felker et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Peripheral Vascular Disease

Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure

Christopher Stuart Wilcox et al.

HYPERTENSION (2020)

Article Cardiac & Cardiovascular Systems

Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial

Stephen J. Greene et al.

CANADIAN JOURNAL OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Lung Ultrasound in Acute Heart Failure Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes

Elke Platz et al.

JACC-HEART FAILURE (2019)

Review Endocrinology & Metabolism

Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis

Karen M. Hallow et al.

DIABETES OBESITY & METABOLISM (2018)

Article Cardiac & Cardiovascular Systems

Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload

Marvin A. Konstam et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Urology & Nephrology

Diuretic Resistance

Ewout J. Hoorn et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2017)

Review Cardiac & Cardiovascular Systems

Diuretic response in acute heart failure -pathophysiology, evaluation, and therapy

Jozine M. ter Maaten et al.

NATURE REVIEWS CARDIOLOGY (2015)

Article Medicine, General & Internal

Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction The ROSE Acute Heart Failure Randomized Trial

Horng H. Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Medicine, General & Internal

Diuretic Strategies in Patients with Acute Decompensated Heart Failure

G. Michael Felker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial

Marvin A. Konstam et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Cardiac & Cardiovascular Systems

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure

Maria Rosa Costanzo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)